Copyright
©The Author(s) 2024.
World J Clin Cases. Aug 16, 2024; 12(23): 5422-5430
Published online Aug 16, 2024. doi: 10.12998/wjcc.v12.i23.5422
Published online Aug 16, 2024. doi: 10.12998/wjcc.v12.i23.5422
Number | Organic acids (normal range) | |
1 | Lactic acid -2 (0.0-13.0) | 14.2↑ |
2 | Pyruvate-OX-2 (0.0-30.0) | 91.7↑ |
3 | 2-hydroxyisovaleric acid-2 (0.0-2.0) | 7.8↑ |
4 | 2-ketoisovaleric acid-OX-2 (0.0-0.3) | 1.0↑ |
5 | 2-ketoisohexanoic acid-OX-2 (0.0-0.8) | 1.7↑ |
6 | Glutaric acid -2 (0.0-8.0) | 516.4↑ |
7 | Isoamyl glycine-1 (0.0-1.5) | 11.3↑ |
8 | Acetylmalonic acid-2 (0.0-7.0) | 17.6↑ |
9 | Methylsuccinic acid-2 (0.0-4.0) | 5.5↑ |
10 | Methyl fumaric acid-2 (0.0-2.5) | 3.0↑ |
11 | Glutaconic acid-2 (0.0-0.0) | 2.2↑ |
12 | Adipic acid-2 (0.0-15.0) | 165↑ |
Amino acid and acylcarnitine spectrum (normal range) | Amino acid and acylcarnitine spectrum | ||
Palmitoyl carnitine (C16) (0.20-3.50) | 4.49↑ | C8/C3 (0.01-0.40) | 1.20↑ |
Palmitoyl carnitine (C16:1) (0.02-0.30) | 2.22↑ | C10/C3 (0.01-0.50) | 2.70↑ |
Palmolive dienyl carnitine (C16:2) (0.01-0.10) | 0.31↑ | C12/C3 (0.01-0.35) | 3.58↑ |
Octadecyl carnitine (C18:1) (0.20-2.80) | 3.80↑ | C14/C3 (0.02-0.45) | 9.25↑ |
C3/Mot (0.02-0.30) | 0.01↓ | C14:1/C8:1 (0.10-6.00) | 12.31↑ |
C3DC/C4 (0.10-1.50) | 0.07↓ | C16/C2 (0.01-0.20) | 0.82↑ |
C4/C2 (0.00-0.05) | 0.08↑ | C16/C3 (0.10-3.50) | 22.07↑ |
C4/C3 (0.00-0.70) | 2.15↑ | C18/C3 (0.05-2.00) | 5.44↑ |
C5/C2 (0.00-0.05) | 0.12↑ | C16 OH/C3 (0.00-0.15) | 0.22↑ |
C5/C3 (0.00-0.50) | 3.20↑ | C18 OH/C3 (0.00-0.10) | 0.17↑ |
C5DC/C3 (0.01-0.40) | 0.65↑ | (C1G+C18:1)/C2 (0.03-0.40) | 1.52↑ |
C6/C3 (0.01-0.30) | 0.72↑ | C0/(C1G+C18) (6.50-90.00) | 1.12↓ |
- Citation: Li XX, Yang XN, Pan HD, Liu L. Fatal multiple acyl-CoA dehydrogenase deficiency caused by ETFDH gene mutation: A case report. World J Clin Cases 2024; 12(23): 5422-5430
- URL: https://www.wjgnet.com/2307-8960/full/v12/i23/5422.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i23.5422